Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
17m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
17m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
18m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
18m agoFirst Quantum Minerals Reports First Quarter 2026 Results
18m agoDistrict Metals Announces $10 Million Private Placement Financing

Tvrd

About

Tvrd (NASDAQ:TVRD) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 2 2026
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
Mar 31 2026
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Feb 12 2026
Tvardi Therapeutics to Participate in Upcoming Investor Conferences
Jan 8 2026
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Jan 8 2026
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights

Financials

Revenue
$0
Market Cap
$27.77 M
EPS
-3.26

Community Chat

Ask AI

6ix6ixAIEvents